# A Clinical Trial to Evaluate the Bioequivalence of AD-116A and AD-1161 Under Fed Conditions in Healthy Adult Male Volunteers

> **NCT07722871** · PHASE1 · NOT_YET_RECRUITING · sponsor: **Addpharma Inc.** · enrollment: 44 (estimated)

## Conditions studied

- Benign Prostatic Hyperplasia

## Interventions

- **DRUG:** AD-116A
- **DRUG:** AD-1161

## Key facts

- **NCT ID:** NCT07722871
- **Lead sponsor:** Addpharma Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-07
- **Primary completion:** 2026-10
- **Final completion:** 2026-10
- **Target enrollment:** 44 (ESTIMATED)
- **Last updated:** 2026-07-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07722871

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07722871, "A Clinical Trial to Evaluate the Bioequivalence of AD-116A and AD-1161 Under Fed Conditions in Healthy Adult Male Volunteers". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07722871. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*